{"entity":{"id":"benjamin-kasenda","kind":"person","name":"Benjamin Kasenda","aka":[],"tldr":"Basel haematologist-oncologist who co-led phase 2 trials of high-dose chemotherapy and autologous transplant in primary CNS lymphoma.","summary":"Benjamin Kasenda is a senior physician in internal medicine and haematology/oncology at Universitätsspital Basel, working within the Tumour Centre with a focus on gastrointestinal tumours and lymphoma. He has co-authored prospective phase 2 trials in the Lancet Haematology evaluating high-dose chemotherapy with autologous stem-cell transplantation for primary CNS lymphoma, including in older patients.","asOf":"2026-09-10","links":[{"label":"Institution profile","url":"https://www.unispital-basel.ch/en/tumorzentrum"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Kasenda+B%5BAuthor%5D"}],"tags":["clinician-scientist","lymphoma","haematology"],"related":[],"cancers":["primary-cns-lymphoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["usb-basel"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Senior Physician, Medical Oncology and Haematology (Tumour Centre)","institutionId":"usb-basel","specialisms":["Primary CNS lymphoma","Gastrointestinal tumours","Haematology-oncology","Clinical trials"],"profiles":[{"label":"Institution profile","url":"https://www.unispital-basel.ch/en/tumorzentrum"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Kasenda+B%5BAuthor%5D"}],"papers":[{"title":"High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial","journal":"Lancet Haematology","year":2016,"url":"https://doi.org/10.1016/S2352-3026(16)30050-3","doi":"10.1016/S2352-3026(16)30050-3"},{"title":"High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial","journal":"Lancet Haematology","year":2024,"url":"https://doi.org/10.1016/S2352-3026(23)00371-X","doi":"10.1016/S2352-3026(23)00371-X"}],"orcid":"0000-0003-0110-8585"},"route":"/people/benjamin-kasenda/","neighbours":{"cancer":[{"id":"primary-cns-lymphoma","kind":"cancer","name":"Primary CNS lymphoma","route":"/cancers/primary-cns-lymphoma/"}],"institution":[{"id":"usb-basel","kind":"institution","name":"University Hospital Basel / Tumour Centre","route":"/institutions/usb-basel/"}]}}